Updates in Clinical Trials in Gene Therapy for Hemophilia A

Updates in Clinical Trials in Gene Therapy for Hemophilia A

Listen as Dr. Margareth Ozelo from the University of Campinas in Brazil discusses the latest clinical trial updates in Gene Therapy for Hemophilia A. 

This podcast is part of a comprehensive educational resource designed by leading experts for the global hemophilia community to help you stay abreast of the evolving science and latest clinical advancements in gene therapy in hemophilia. Visit www.genetherapy.isth.org for more information.

Margareth C. Ozelo, MD, PhD
Margareth C. Ozelo, MD, PhD
University of Campinas
Hemocentro UNICAMP, Brazil
Campinas, São Paulo, Brazil

Dr. Margareth C. Ozelo is Associate Professor of Internal Medicine Department, and Director of the Haematology Division from University of Campinas (UNICAMP) in Campinas, São Paulo, Brazil. She received her medical degree (1994), specialist training in haematology and transfusion medicine (1994-1997), and PhD (2004) at UNICAMP before undertaking a postdoctoral fellowship in David Lillicrap’s laboratory, at Queen’s University in Kingston, Ontario, Canada, focused in gene therapy for haemophilia (2006–2009).

Dr. Ozelo is also the Director of the WFH International Haemophilia Training Centre (IHTC) from Hemocentro UNICAMP. In 2012, she was nominated as a member of the Novo Nordisk Haemophilia Foundation Council and was member of the Executive Committee of the World Federation of Haemophilia from 2012 to 2014.

Dr Ozelo is involved with several research projects, including, gene therapy for haemophilia, risk factors for inhibitor development, immune tolerance induction, and the management of musculoskeletal complications of haemophilia, and inherited platelet disorders.

Image

Please enable the javascript to submit this form

Supported through educational grants from BioMarin, CSL Behring, Pfizer Inc., and Spark Therapeutics

Essential SSL